CC
GRTS

Casdin Capital’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Casdin Capital’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,850,373
Closed -$12.3M – 48
2020
Q2 		$12.3M Sell
1,850,373
-419,627
-18% -$2.83M 0.73% 31
2020
Q1 		$13.2M Buy
2,270,000
+110,000
+5% +$924K 1.4% 22
2019
Q4 		$19.4M Buy
2,160,000
+390,000
+22% +$3.25M 1.78% 19
2019
Q3 		$15.3M Hold
1,770,000
– – 1.58% 19
2019
Q2 		$19.7M Buy
1,770,000
+649,414
+58% +$7.43M 1.85% 19
2019
Q1 		$14.9M Buy
1,120,586
+400,000
+56% +$5.35M 1.64% 20
2018
Q4 		$11.1M Hold
720,586
– – 1.9% 20
2018
Q3 		$10.3M Buy
+720,586
New +$10.3M 1.25% 23

Other funds holding GRTS

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital's GRTS Position: Q3 2020 in Review

Casdin Capital sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2020, closing a stake of 1,850,373 shares — an estimated $12.3M sold.

Casdin Capital first reported a position in GRTS in Q3 2018 and held it in 8 quarters. The position peaked at $19.7M in Q2 2019. 69 funds tracked by Wall St. Rank hold GRTS as of Q3 2020.

  • Casdin Capital reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Casdin Capital sold 1,850,373 Gritstone bio, Inc. Common Stock shares in Q3 2020, an estimated $12.3M.
  • Casdin Capital first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Casdin Capital's Gritstone bio, Inc. Common Stock position peaked at $19.7M in Q2 2019.
  • 69 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2020.

Based on Casdin Capital's 13F filing for Q3 2020, filed 16 Nov 2020.